Granger, Christopher B.

Major Bleeding in Patients With Atrial Fibrillation Receiving Apixaban or Warfarin

Hylek, E. M., Held, C., Alexander, J. H., Lopes, R. D., De Caterina, R., Wojdyla, D. M., Huber, K., Jansky, P., Steg, P. G., Hanna, M., et al. (2014) · Journal of the American College of Cardiology

Atrial Fibrillation Management and OutcomesVenous Thromboembolism Diagnosis and Management

Cited by 344

Registry-based randomized clinical trials—a new clinical trial paradigm

James, S., Rao, S. V., & Granger, C. B. (2015) · Nature Reviews Cardiology

Statistical Methods in Clinical TrialsMeta-analysis and systematic reviews

Cited by 331

2016 ACC/AHA guideline focused update on duration of dual antiplatelet therapy in patients with coronary artery disease

Levine, G. N., Bates, E. R., Bittl, J. A., Brindis, R. G., Fihn, S. D., Fleisher, L. A., Granger, C. B., Lange, R. A., Mack, M. J., Mauri, L., et al. (2016) · The Journal of Thoracic and Cardiovascular Surgery

Antiplatelet Therapy and Cardiovascular DiseasesCoronary Interventions and Diagnostics

Cited by 304

Biomarkers in atrial fibrillation: a clinical review

Hijazi, Z., Oldgren, J., Siegbahn, A., Granger, C. B., & Wallentin, L. (2013) · European Heart Journal

Atrial Fibrillation Management and OutcomesInflammatory Biomarkers in Disease Prognosis

Cited by 298

Demographics, Care Patterns, and Outcomes of Patients Admitted to Cardiac Intensive Care Units: The Critical Care Cardiology Trials Network Prospective North American Multicenter Registry of Cardiac Critical Illness

Bohula, E. A., Katz, J. N., van Diepen, S., Alviar, C. L., Baird-Zars, V. M., Park, J.-G., Barnett, C. F., Bhattal, G., Barsness, G. W., Burke, J. A., et al. (2019) · JAMA Cardiology

Acute Myocardial Infarction ResearchGlobal Health and Epidemiology

Cited by 261

N-Terminal Pro–B-Type Natriuretic Peptide for Risk Assessment in Patients With Atrial Fibrillation

Hijazi, Z., Wallentin, L., Siegbahn, A., Andersson, U., Christersson, C., Ezekowitz, J., Gersh, B. J., Hanna, M., Hohnloser, S., Horowitz, J., et al. (2013) · Journal of the American College of Cardiology

Atrial Fibrillation Management and OutcomesHeart Failure Treatment and Management

Cited by 231

Analysing recurrent hospitalizations in heart failure: a review of statistical methodology, with application to CHARM-Preserved

Rogers, J. K., Pocock, S. J., McMurray, J. J. V., Granger, C. B., Michelson, E. L., Östergren, J., Pfeffer, M. A., Solomon, S. D., Swedberg, K., & Yusuf, S. (2014) · European Journal of Heart Failure

Heart Failure Treatment and ManagementStatistical Methods in Clinical Trials

Cited by 226

Incidence and Predictors of Hyperkalemia in Patients With Heart Failure

Desai, A. S., Swedberg, K., McMurray, J. J. V., Granger, C. B., Yusuf, S., Young, J. B., Dunlap, M. E., Solomon, S. D., Hainer, J. W., Olofsson, B., et al. (2007) · Journal of the American College of Cardiology

Potassium and Related DisordersHeart Failure Treatment and Management

Cited by 170

Influence of Previous Heart Failure Hospitalization on Cardiovascular Events in Patients With Reduced and Preserved Ejection Fraction

Bello, N. A., Claggett, B., Desai, A. S., McMurray, J. J. V., Granger, C. B., Yusuf, S., Swedberg, K., Pfeffer, M. A., & Solomon, S. D. (2014) · Circulation: Heart Failure

Heart Failure Treatment and ManagementCardiovascular Function and Risk Factors

Cited by 147

Effect of Loading Dose of Atorvastatin Prior to Planned Percutaneous Coronary Intervention on Major Adverse Cardiovascular Events in Acute Coronary Syndrome: The SECURE-PCI Randomized Clinical Trial

Berwanger, O., Santucci, E. V., de Barros e Silva, P. G. M., Jesuíno, I. D. A., Damiani, L. P., Barbosa, L. M., Santos, R. H. N., Laranjeira, L. N., Egydio, F. D. M., Borges de Oliveira, J. A., et al. (2018) · JAMA

Lipoproteins and Cardiovascular HealthAcute Myocardial Infarction Research

Cited by 131

The role of bystanders, first responders, and emergency medical service providers in timely defibrillation and related outcomes after out-of-hospital cardiac arrest: Results from a statewide registry

Hansen, C. M., Kragholm, K., Granger, C. B., Pearson, D. A., Tyson, C., Monk, L., Corbett, C., Nelson, R. D., Dupre, M. E., Fosbøl, E. L., et al. (2015) · Resuscitation

Cardiac Arrest and ResuscitationPalliative Care and End-of-Life Issues

Cited by 125

Guidelines for Cardiovascular Risk Reduction in Patients With Type 2 Diabetes

Kelsey, M. D., Nelson, A. J., Green, J. B., Granger, C. B., Peterson, E. D., McGuire, D. K., & Pagidipati, N. J. (2022) · Journal of the American College of Cardiology

Diabetes Treatment and ManagementDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 106

SYNTAX Score and Long-Term Outcomes

Ikeno, F., Brooks, M. M., Nakagawa, K., Kim, M.-K., Kaneda, H., Mitsutake, Y., Vlachos, H. A., Schwartz, L., Frye, R. L., Kelsey, S. F., et al. (2017) · Journal of the American College of Cardiology

Coronary Interventions and DiagnosticsCardiac Imaging and Diagnostics

Cited by 85

Prevalence of Prediabetes and Undiagnosed Diabetes in Patients with HFpEF and HFrEF and Associated Clinical Outcomes

CHARM Investigators and Committees, Kristensen, S. L., Jhund, P. S., Lee, M. M. Y., Køber, L., Solomon, S. D., Granger, C. B., Yusuf, S., Pfeffer, M. A., Swedberg, K., et al. (2017) · Cardiovascular Drugs and Therapy

Heart Failure Treatment and ManagementCardiovascular Function and Risk Factors

Cited by 83

Impact of a statewide ST-segment-elevation myocardial infarction regionalization program on treatment times for women, minorities, and the elderly

Glickman, S. W., Granger, C. B., Ou, F.-S., O'Brien, S., Lytle, B. L., Cairns, C. B., Mears, G., Hoekstra, J. W., Garvey, J. L., Peterson, E. D., et al. (2010) · Circulation Cardiovascular Quality and Outcomes

Acute Myocardial Infarction ResearchCoronary Interventions and Diagnostics

Cited by 80

Use of Lipid-, Blood Pressure–, and Glucose-Lowering Pharmacotherapy in Patients With Type 2 Diabetes and Atherosclerotic Cardiovascular Disease

Nelson, A. J., O’Brien, E. C., Kaltenbach, L. A., Green, J. B., Lopes, R. D., Morse, C. G., Al-Khalidi, H. R., Aroda, V. R., Cavender, M. A., Gaynor, T., et al. (2022) · JAMA Network Open

Diabetes Treatment and ManagementDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 78

Predictors of Development of Diabetes in Patients With Chronic Heart Failure in the Candesartan in Heart Failure Assessment of Reduction in Mortality and Morbidity (CHARM) Program

Preiss, D., Zetterstrand, S., McMurray, J. J. V., Östergren, J., Michelson, E. L., Granger, C. B., Yusuf, S., Swedberg, K., Pfeffer, M. A., Gerstein, H. C., et al. (2009) · Diabetes Care

Heart Failure Treatment and ManagementDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 76

Worsening Renal Function and Outcome in Heart Failure Patients with Reduced and Preserved Ejection Fraction and the Impact of Angiotensin Receptor Blocker Treatment: Data from the CHARM-Study Programme

Damman, K., Solomon, S. D., Pfeffer, M. A., Swedberg, K., Yusuf, S., Young, J. B., Rouleau, J. L., Granger, C. B., & McMurray, J. J. V. (2016) · European Journal of Heart Failure

Heart Failure Treatment and ManagementChronic Kidney Disease and Diabetes

Cited by 75

Transfusion and mortality in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention

Jolicœur, E. M., O'Neill, W. W., Hellkamp, A., Hamm, C. W., Holmes, D. R., Al-Khalidi, H. R., Patel, M. R., Van de Werf, F. J., Pieper, K., Armstrong, P. W., et al. (2009) · European Heart Journal

Blood transfusion and managementAcute Myocardial Infarction Research

Cited by 54

Racial differences in the management of unstable angina: Results from the multicenter GUARANTEE registry

Scirica, B. M., Moliterno, D. J., Every, N. R., Anderson, H. V., Aguirre, F. V., Granger, C. B., Lambrew, C. T., Rabbani, L. E., Sapp, S. K., Booth, J. E., et al. (1999) · American Heart Journal

Coronary Interventions and DiagnosticsCardiac Imaging and Diagnostics

Cited by 36

Cardiovascular event reduction among a US population eligible for semaglutide per the SELECT trial

Lusk, J. B., Glover, L., Soneji, S., Granger, C. B., O'Brien, E., & Pagidipati, N. (2024) · American Heart Journal

Diabetes Treatment and ManagementDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 9

Risk of Total Events With Icosapent Ethyl

Granger, C. B., Nelson, A. J., & Pagidipati, N. J. (2019) · Journal of the American College of Cardiology

Fatty Acid Research and HealthLipoproteins and Cardiovascular Health

Cited by 8